Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-06-12

Clinical Trial Update: Taxane and Taxane-Induced Peripheral Neuropathy in African American Patients With Stage I-III Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial in African American patients with Stage I-III breast cancer reports results on taxane therapy and taxane-induced peripheral neuropathy; r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DOCETAXEL (DOCETAXEL)
  • PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: ECOG-ACRIN Cancer Research Group | Conditions: Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8 | Phase 2 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2024-06-12